29 Programs

  • Current and Future Management of HER2-Altered Non-Small Cell Lung Cancer

    Explore program
    • November 2025 1.25 ABIM MOC, ABS MOC, CME 1h 5min
      • J
      Dr Heymach
    • November 2025 0.75 ABIM MOC, ABS MOC, CME 26min
      • J
      Dr Heymach
  • The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer

    Explore program
  • Key Presentations from the 2025 ASCO Annual Meeting and the EHA 2025 Congress — Acute Myeloid Leukemia Edition

    Explore program
    • October 2025 1.25 ABIM MOC, ABS MOC, CME 54min
      • E
      Dr Wang
    • October 2025 0.75 ABIM MOC, ABS MOC, CME 34min
      • E
      Dr Wang
  • Optimizing the Integration of ADCs into the Treatment of HR-Positive and Triple-Negative Metastatic Breast Cancer

    Explore program
    • October 2025 1 ABIM MOC, ABS MOC, CME 43min
      • L
      Dr Huppert
    • October 2025 0.75 ABIM MOC, ABS MOC, CME 31min
      • L
      Dr Huppert